Received Jul 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | A99T7 | RA |
tingling in left hand/face tingling on the left side; heart pain; pain in shoulder; This serious case was reported by a consumer via sales rep and described the occurrence of tingling in a 59-year-old male patient who received DTPa (Reduced antigen) (Boostrix) solution for injection (batch number A99T7 with expiry date 17-OCT-2028) for prophylaxis. The patient's past medical history included skin abrasion. On 05-JUL-2026, the patient received Boostrix (right arm). On 05-JUL-2026, less than a day after receiving Boostrix, the patient experienced tingling (Verbatim: tingling in left hand/face tingling on the left side) (serious criteria other: serious as per reporter), cardiac pain (Verbatim: heart pain) (serious criteria GSK medically significant) and shoulder pain (Verbatim: pain in shoulder). The outcome of the tingling was not resolved and the outcome of the cardiac pain and shoulder pain were not reported. The reporter considered the tingling to be related to Boostrix. It was unknown if the reporter considered the cardiac pain and shoulder pain to be related to Boostrix. The company considered the tingling and cardiac pain to be unrelated to Boostrix. Additional Information: GSK Receipt Date: 07-JUL-2026 The patient went for a tetanus shot but was given Boostrix, which contained the whooping cough component. The patient went for tetanus vaccination because they had scraped their arm on metal. The patient was suggested that the whooping cough vaccine should be taken off the market as it had a common chance of side effects, with a 17 to 22 percent possibility and a small chance of getting whooping cough of 0.05 percent.; Sender's Comments: A case of Paraesthesia and Angina pectoris, less than a day after vaccination with unknown dose of Boostrix, in a 59-year-old male patient. Based on the available information, a possible causality that the events were caused by the GSK product cannot be ascertained. Further follow-up information has been sought.
Medical History/Concurrent Conditions: Skin abrasion